Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy of Anti-BCMA/GPRC5D CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma(rr/MM)
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Study of Carfilzomib, Pomalidomide, and Dexamethasone for Myeloma Patients Who Had Relapsed or Progressed After Carfilzomib, Lenalidomide, and Dexamethasone
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Carfilzomib, Lenalidomide, and Dexamethasone Re-induction Followed by the 2nd ASCT in Multiple Myeloma Patients Relapsed After the 1st ASCT
- Status
- RECRUITING
- Phase
- PHASE2
Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Selinexor, Pomalidomide, and Dexamethasone For Multiple Myeloma With CNS Involvement
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trial to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Multiple Myeloma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
- Status
- RECRUITING
- Phase
- PHASE2
Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- NA
Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
- Status
- RECRUITING
- Phase
- NA
Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Daratumumab
- Status
- RECRUITING
- Phase
- PHASE3
COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
PVd Versus Vd in NDMM Patients With RI
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of MCARH109 and MCARH125 in People With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1